Frequent Links
powder metallurgy review journalsAntirheumatic drugs Peer-review JournalsFamily care Ethical dilemma Top Open Access JournalsBioreceptorPeer-reviewed journals in Information TechnologyCellular stress Scholarly Peer-review JournalAlzheimerSimulationWeed management Articlesprotein cysteinePhysical dependence Open Access ArticlesOpen Access Food Industry JournalsZoology Peer-review JournalsCosmetic Dentistry Scholarly Peer-review Journal
Terbequinil
File:Terbequinil structure.png | |
Ball-and-stick model of the terbequinil molecule | |
Systematic (IUPAC) name | |
---|---|
1-(methoxymethyl)-4-oxo-N-propylquinoline-3-carboxamide | |
Clinical data | |
Identifiers | |
113079-82-6 7px | |
None | |
PubChem | CID 65916 |
ChemSpider | 59325 7px |
UNII | 0DH9WUS03O 7px |
Chemical data | |
Formula | C15H18N2O3 |
274.315 g/mol | |
| |
14px (what is this?) (verify) |
Terbequinil (SR-25776) is a stimulant and nootropic drug which acts as a partial inverse agonist at benzodiazepine sites on the GABAA receptor. In human trials it was found to partially reverse the sedative and amnestic effects of the hypnotic drug triazolam with only slight effects when administered by itself.[1]
See also
References
- ^ Warot D, Danjou P, Douillet P, Keane P, Puech AJ. Cognitive impairments induced by triazolam in healthy volunteers: antagonism by a partial inverse agonist of benzodiazepine receptor. Therapie. 1994 Jan-Feb;49(1):23-6. PMID 8091361
|